As of January 22, 2025, PolyPeptide Group (PPGN.SW) has a market cap of $0.99 billion USD. According to our data, PolyPeptide Group is ranked No.5213 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.99 B |
-3.87%
|
Dec 30, 2024 | $1.03 B |
62.10%
|
Dec 29, 2023 | $0.64 B |
-30.81%
|
Dec 30, 2022 | $0.92 B |
-81.45%
|
Dec 30, 2021 | $4.97 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Amgen
AMGN
|
$147.53 B |
0.002 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
-0.001 M
|
USA
|
Gilead Sciences
GILD
|
$116.07 B |
0.004 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$75.23 B |
1.245 B
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.70 B |
-0.001 M
|
USA
|
Moderna
MRNA
|
$14.88 B |
0.000 M
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.81 B |
-0.000 M
|
USA
|
Incyte
INCY
|
$14.05 B |
-0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.39 B |
-0.001 M
|
USA
|
Sarepta Therapeutics
SRPT
|
$11.08 B |
-0.000 M
|
USA
|
Ionis Pharmaceuticals
IONS
|
$5.19 B |
0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.82 B |
6.828 M
|
Switzerland
|
bluebird bio
BLUE
|
$77.02 M |
0.000 M
|
USA
|
Editas Medicine
EDIT
|
$0.10 B |
-0.000 M
|
USA
|
Market Cap | = | PPGN.SW Stock Price | * | PPGN.SW Shares Outstanding |
= | $30.14 | * | 32.98 M | |
= | $0.99 B |